Inhibition of adhesion of Clostridium difficile to Caco-2 cells

FEMS Immunology and Medical Microbiology

Volumn 14, Issue 4, 1996, Pages 205-209

  Naaber, Paul ^a   Lehto, Elina ^b   Salminen, Seppo ^b   Mikelsaar, Marika ^a  

^a UNIVERSITY OF TARTU   (Estonia)

^b UNIVERSITY OF TURKU   (Finland)

Author keywords

Caco 2 cell; Clostridium difficile; Colostrum; Mucosal adhesion; Xylitol

Indexed keywords

XYLITOL;

ARTICLE; BACTERIUM ADHERENCE; CELL LINE; CLOSTRIDIUM DIFFICILE; COLITIS; COLOSTRUM; DIARRHEA; HUMAN; HUMAN CELL; INTESTINE MUCOSA; PRIORITY JOURNAL;

EID: 0030199919     PISSN: 09288244     EISSN: None     Source Type: Journal    
DOI: 10.1016/0928-8244(96)00031-4     Document Type: Article

References (16)

1. [1] Aronson, M., Mdalia, D. and Schori, L. (1979) Prevention of colonisation of the urinary tract of mice with E. coli by blocking of bacterial adherence with methyl-D-mannopyranoside. J. Infect. Dis. 139, 560
2. [2] Borriello, S.P. (1990) Pathogenesis of Clostridium difficile infection of the gut. J. Med. Microbiol. 33, 207-215.
3. [3] Borriello, S.P., Welch, A.R., Barclay, F.E. and Davies, H.A. (1988) Mucosal association by Clostridium difficile in the hamster gastrointestinal tract. J. Med. Microbiol. 25, 191-196.
4. [4] Eveillard, M., Fourel, V., Barc, M.C., Coconnier, M.H., Karjalainen, T., Bourlioux, P. and Servin, A.L. (1993) Identification and characterization of adhesive factors of Clostridium difficile involved in adhesion to human colonic enterocyte-like Caco-2 and mucus secreting HT29 cells in culture. Mol. Microbiol. 7, 371-381.
5. [5] Karjalainen, T., Barc, M.C., Collignon, A., Trolle, S., Boureau, H., Cotte-Laffitte, J. and Bourlioux, P. (1994) Cloning of the genetic determinant from Clostridium difficile involved in adherence to tissue culture cells and mucus. Infect. Immun. 10. 4347-4355.
6. [6] Kelly, C.P., Pothoulkis, C., Vavva, F., Castagliuolo, I., Bostwick, E.F., O'Keane, J.C., Keats, S. and LaMont, J.T. (1996) Anti-Clostridium difficile bovine immunoglobulin concentrate inhibits cytotoxity and enterotoxity of C. difficile toxins. Antimicrob. Agents Chemother. 40, 373-379
7. [7] Korhonen, H., Meriläinen, V. and Antila, M. (1978) The composition and meaning of colostrum for the new-born calf. In Finnish. Soum. Eläin. 87, 375.
8. [8] Lyerly, D.M., Krivan, H.C. and Wilkins, T.D. (1988) Clostridium difficile: Its disease and toxins. Clin. Microbiol. Rev. 1, 1-18.
9. [9] McClane, B.A. (1995) ASM First International Conference on the Molecular Genetics and Pathogenesis of the Clostridia. ASM News 61, 465-468.
10. [10] Mäkinen, K.K. (1978) Biochemical principles of the use of xylitol in medicine and nutrition with special consideration of dental aspects. Experimentia Suppl. 30, 1.
11. [11] Pinto, M., et al. (1983) Enterocyte-like differentiation and polarization of the human colon carcinoma cell line Caco-2 in culture. Biol. Cell 47, 323-330.
12. [12] Rolfe, R.D. and Song, W. (1994) Immunoglobulin and nonimmunoglobulin components of human milk inhibit Clostridium difficile toxin A-receptor binding. Abstract: XIX International Congress on Microbial Ecology and Disease, Rome, September 18-21, 1994, 55.
13. [13] Salminen, S. Salminen, E., Koivistoinen, P., Bridges, J. and Marks, V. (1985) Gut microflora interactions with xylitol in mouse, rat and man. Food Chem. Toxic. 11, 985-990.
14. [14] Stephan, W., Dichetelmueller, H. and Lissner, R. (1990) Antibodies from colostrum in oral immunotherapy. J. Clin. Chem. Clin. Biochem. 28, 19.
15. [15] Tacket, C.O., Losonsky, G., Link, H., Hoang, Y., Guesry, P., Hilpert, H. and Levine, M.M. (1988) Protection by milk immunoglobulin concentrate against oral challenge with enterotoxigenic Escherichia coli. New Engl. J. Med. 318, 1240.
16. [16] Wilson, K.H. (1993) The microecology of Clostridium difficile. Clin. Infect. Dis. 16. Suppl. 4. S214-219.